Stratec SE
XETRA:SBS

Watchlist Manager
Stratec SE Logo
Stratec SE
XETRA:SBS
Watchlist
Price: 22.65 EUR -1.09% Market Closed
Market Cap: 275.4m EUR

Stratec SE
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Stratec SE
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Stratec SE
XETRA:SBS
Cash from Operating Activities
€21.8m
CAGR 3-Years
-15%
CAGR 5-Years
-6%
CAGR 10-Years
-5%
Carl Zeiss Meditec AG
XETRA:AFX
Cash from Operating Activities
€195.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
Cash from Operating Activities
€66.5m
CAGR 3-Years
32%
CAGR 5-Years
19%
CAGR 10-Years
15%
Siemens Healthineers AG
XETRA:SHL
Cash from Operating Activities
€3.5B
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Draegerwerk AG & Co KGaA
XETRA:DRW8
Cash from Operating Activities
€203m
CAGR 3-Years
N/A
CAGR 5-Years
2%
CAGR 10-Years
6%
Sartorius AG
XETRA:SRT
Cash from Operating Activities
€874.3m
CAGR 3-Years
9%
CAGR 5-Years
12%
CAGR 10-Years
20%
No Stocks Found

Stratec SE
Glance View

Market Cap
275.3m EUR
Industry
Health Care

STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. The company is headquartered in Birkenfeld, Baden-Wuerttemberg and currently employs 1,398 full-time employees. Its business activities are divided into three segments: Instrumentation, which designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers; Diatron, which offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications, and Consumables, which develops and sells scientific materials, such as nucleic acid purification and designs and produces smart consumables in the fields of diagnostics, life sciences, and medical technology. In addition, the Company develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies.

SBS Intrinsic Value
44.57 EUR
Undervaluation 49%
Intrinsic Value
Price

See Also

What is Stratec SE's Cash from Operating Activities?
Cash from Operating Activities
21.8m EUR

Based on the financial report for Sep 30, 2025, Stratec SE's Cash from Operating Activities amounts to 21.8m EUR.

What is Stratec SE's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-5%

Over the last year, the Cash from Operating Activities growth was -36%. The average annual Cash from Operating Activities growth rates for Stratec SE have been -15% over the past three years , -6% over the past five years , and -5% over the past ten years .

Back to Top